Cerus Corporation (CERS) reported first-quarter 2026 revenue of $59.9 million, up 22.6% year-over-year and above the consensus estimate of $54.2 million. Gross profit reached $34.1 million, a 9.95% increase from a year earlier.
Profitability details showed an operating loss of -$354,000, a decline of 93.95% year-over-year, and a net loss attributable to common shareholders of -$1.6 million, down 89.37% versus Q1 a year ago. Diluted earnings per share was -0.01, an improvement versus the estimate of -0.04.
On the cash and balance sheet front, cash from operating activities was $6.2 million while purchases of property and equipment totaled -$1.3 million. The company held $27.9 million in cash and cash equivalents at quarter end. Cost of sales rose to $25.8 million, and total liabilities were $154.6 million.
Market reaction showed shares of CERS up 7.16% since market close, reflecting investor response to the quarter’s top-line beat and the smaller-than-expected loss per share.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Cerus Corporation Insider Trading Activity
Cerus Corporation insiders have traded $CERS stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $CERS stock by insiders over the last 6 months:
- WILLIAM MARINER GREENMAN (President and CEO) has made 0 purchases and 2 sales selling 525,944 shares for an estimated $898,826.
- RICHARD J BENJAMIN (Chief Medical Officer) has made 0 purchases and 4 sales selling 227,634 shares for an estimated $419,541.
- KEVIN DENNIS GREEN (Chief Financial Officer) has made 0 purchases and 3 sales selling 210,565 shares for an estimated $381,012.
- VIVEK K JAYARAMAN (Chief Operating Officer) has made 0 purchases and 2 sales selling 199,294 shares for an estimated $342,144.
- CHRYSTAL JENSEN (Chief Legal Officer) has made 0 purchases and 2 sales selling 85,845 shares for an estimated $155,359.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
Cerus Corporation Hedge Fund Activity
We have seen 74 institutional investors add shares of Cerus Corporation stock to their portfolio, and 69 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOLEUS CAPITAL MANAGEMENT, L.P. added 4,000,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $8,240,000
- MILLENNIUM MANAGEMENT LLC removed 2,502,368 shares (-72.1%) from their portfolio in Q4 2025, for an estimated $5,154,878
- AMOVA ASSET MANAGEMENT AMERICAS, INC. removed 975,218 shares (-17.2%) from their portfolio in Q4 2025, for an estimated $2,008,949
- BLACKROCK, INC. added 938,737 shares (+4.5%) to their portfolio in Q4 2025, for an estimated $1,933,798
- UBS GROUP AG added 793,244 shares (+227.1%) to their portfolio in Q4 2025, for an estimated $1,634,082
- TWO SIGMA INVESTMENTS, LP added 712,678 shares (+62.3%) to their portfolio in Q4 2025, for an estimated $1,468,116
- ARK INVESTMENT MANAGEMENT LLC removed 649,984 shares (-3.4%) from their portfolio in Q4 2025, for an estimated $1,338,967
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
Cerus Corporation Government Contracts
We have seen $750,843 of award payments to $CERS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- 25-007944 INTERCEPT PLATELET PROCESSING SETS: $115,699
- INTERCEPT PLATELET PROCESSING KITS: $77,888
- INTERCEPT BLOOD SYSTEM FOR PLATELETS AND PLASMA PATHOGEN REDUCTION SYSTEM AT ARMED SERVICES BLOOD BANK.: $73,176
- INTERCEPT PLATELET PROCESSING SET AND SERVICE MAINTENANCE: $64,626
- INTERCEPT PLATELET SET PN INT2140B: $44,528
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
